What Is SS 31? How Elamipretide Works, Benefits and What to Expect
SS 31, also known as elamipretide and by its brand name Stegazo, is a mitochondrial targeted peptide that works at a level no other peptide therapy can reach. While most peptides act on hormonal receptors or extracellular signaling pathways, SS 31 crosses the cell membrane and concentrates directly inside the mitochondria, where it binds to cardiolipin, the phospholipid that holds the electron transport chain together. This binding stabilizes mitochondrial membrane architecture, restores efficient ATP production, and reduces the oxidative damage that drives cellular aging and disease.
SS 31 is physician prescribed, administered via subcutaneous injection once weekly, and available through licensed U.S. compounding pharmacies. It is not a hormone, not a secretagogue, and not a stimulant. It is a precision intervention at the most fundamental level of cellular energy production.
- SS 31 (elamipretide) is a mitochondrial targeted peptide that crosses the cell membrane and concentrates inside mitochondria at up to 1,000 times the extracellular concentration
- Its primary mechanism is binding to cardiolipin, the phospholipid essential for electron transport chain organization and efficient ATP synthesis
- By stabilizing cardiolipin, SS 31 restores mitochondrial membrane potential, improves ATP production efficiency, and reduces reactive oxygen species (ROS) that cause oxidative damage
- Clinical applications include mitochondrial myopathy, heart failure, chronic fatigue, cognitive decline, and age related mitochondrial dysfunction
- Elamipretide received FDA approval under the brand name Stegazo for Barth syndrome associated cardiomyopathy, and is available through compounding pharmacies for broader clinical applications
- Standard dosing is 37.5 mg once weekly via subcutaneous injection, delivered to your door at $285 per month
How SS 31 Works
Every cell in your body depends on mitochondria for energy. Mitochondria produce ATP, the molecule that powers virtually every cellular process, through the electron transport chain (ETC) embedded in the inner mitochondrial membrane. This membrane's structural integrity depends on a specific phospholipid called cardiolipin, which organizes the ETC complexes into functional units called supercomplexes and ensures electrons transfer efficiently between them.
When cardiolipin is damaged, whether by aging, oxidative stress, or genetic conditions, the ETC disorganizes. Electron transfer becomes inefficient. ATP production drops. Electrons leak out and react with oxygen to form reactive oxygen species (ROS), which cause further damage to cardiolipin, creating a self reinforcing cycle of mitochondrial decline.
SS 31 breaks this cycle. It penetrates the cell membrane, accumulates inside mitochondria at concentrations up to 1,000 times the external level, and binds directly to cardiolipin. This binding stabilizes cardiolipin's interaction with cytochrome c and the ETC complexes, restoring supercomplex organization, improving electron transfer efficiency, increasing ATP output, and reducing ROS generation at the source.
The result is not a temporary energy boost. It is a structural restoration of the machinery your cells use to produce energy.
For the complete cellular mechanism including the cardiolipin interaction, membrane potential restoration, and ROS reduction pathway, see How SS 31 Works at the Cellular Level and SS 31 Overview and Benefits.
Who Is SS 31 For?
SS 31 is appropriate for a broad spectrum of patients whose health concerns trace back to mitochondrial dysfunction, whether from age related decline, chronic disease, or genetic mitochondrial conditions.
Patients who typically benefit most include adults experiencing persistent low energy and chronic fatigue that has not responded adequately to standard interventions; patients with diagnosed or suspected mitochondrial dysfunction; patients with heart failure or cardiovascular conditions where mitochondrial bioenergetics play a role; adults seeking a physician supervised approach to healthy aging and longevity; and athletes or active adults experiencing recovery limitations that may reflect mitochondrial inefficiency.
SS 31 is not appropriate for patients with active or suspected cancer (cell proliferation concerns with any mitochondrial enhancing therapy), women who are pregnant or breastfeeding, or patients with known hypersensitivity to elamipretide or peptide based medications.
For the complete eligibility criteria and patient assessment guide, see Who Is a Candidate for SS 31 Therapy.
For a broader understanding of how peptide therapy works and where SS 31 fits in the landscape, see Comprehensive Guide to Peptide Therapy.
What to Expect and When
How SS 31 Differs From Other Therapies
SS 31 operates at a level that no other available peptide therapy reaches. Sermorelin and CJC 1295 work on the pituitary to stimulate growth hormone. TB 500 promotes tissue repair through actin regulation. MOTS c activates AMPK for metabolic regulation. SS 31 goes directly into the mitochondria and restores the physical architecture of the energy production machinery itself.
This distinction matters because mitochondrial dysfunction is upstream of virtually every age related disease process. When mitochondria work efficiently, every system they power, including the heart, brain, muscles, immune system, and endocrine system, works better. SS 31 addresses the root infrastructure that all other cellular functions depend on.
For the detailed comparison of SS 31 with other peptide therapies and mitochondrial interventions, see SS 31 Compared to Other Peptides. For common misconceptions about what SS 31 can and cannot do, see SS 31 Myths vs Facts.
Frequently Asked Questions
Is SS 31 FDA approved?
Elamipretide (SS 31) received FDA approval under the brand name Stegazo for Barth syndrome associated cardiomyopathy. It is also available through licensed U.S. compounding pharmacies for broader clinical applications via physician prescription.
How is SS 31 administered?
Once weekly subcutaneous injection. Standard dose is 37.5 mg per week (150 mg per month). No daily injections, no oral tablets, no reconstitution required with the compounded formulation.
What does it cost?
$285 per month, delivered to your door with free 2 day shipping. FSA and HSA eligible.
How is SS 31 different from CoQ10 or other mitochondrial supplements?
CoQ10 and other supplements work indirectly and have limited ability to cross into the mitochondrial inner membrane. SS 31 concentrates inside mitochondria at up to 1,000 times the external level and binds directly to cardiolipin, producing structural restoration that supplements cannot replicate.
Disclaimer
This content is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. SS 31 (elamipretide) is available through licensed U.S. compounding pharmacies via physician prescription. Compounded medications are not FDA reviewed for safety, quality, or efficacy as finished products. Consult a licensed healthcare provider before starting, changing, or stopping any treatment. Individual results vary.